packageVorasidenib

vorasidenib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vorasidenib is an anticancer medicine, an IDH inhibitor, used to treat glioma, including oligodendroglioma and astrocytoma. It is authorised in the European Union and is also still under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q122240747 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vorasidenib
ATC codes:L01XM04
DrugBank:DB17097
PubChem CID:117817422
Wikidata:Q122240747
formula:C14H13ClF6N6
molar mass:414.738 g/mol (PubChem CID 117817422)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown